{
    "organizations": [],
    "uuid": "83e462a8524c560bd81c4422bdc0b8f35b3a9623",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-pharmaceuticals-says-on-ma/brief-eyegate-pharmaceuticals-says-on-may-15-board-increased-size-to-eight-from-seven-idUSFWN1SN0YK",
    "ord_in_thread": 0,
    "title": "BRIEF-EyeGate Pharmaceuticals Says On May 15, Board Increased Size To Eight From Seven",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE PHARMACEUTICALS INC - ON MAY 15, BOARD INCREASED SIZE OF BOARD FROM SEVEN DIRECTORS TO EIGHT DIRECTORS - SEC FILING Source bit.ly/2KuxceA Further company coverage:\n ",
    "published": "2018-05-17T04:46:00.000+03:00",
    "crawled": "2018-05-17T14:29:58.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "pharmaceutical",
        "inc",
        "may",
        "board",
        "increased",
        "size",
        "board",
        "seven",
        "director",
        "eight",
        "director",
        "sec",
        "filing",
        "source",
        "company",
        "coverage"
    ]
}